To explore the downstream targets and regulatory network of transmembrane CD83 in ovarian cancer cells without bias, an integrated study of transcriptome and proteome was performed using CD83-OV, CD83-KD, and control SKOV3 cells (Figure S6, Tables S1–4). This evidence concerns the gene CD83 and ovarian carcinoma.